Aadi Bioscience Inc (AADI)
2.345
-0.04
(-1.47%)
USD |
NASDAQ |
Mar 28, 16:00
2.345
0.00 (0.00%)
After-Hours: 19:29
Aadi Bioscience Cash from Financing (TTM): 0.326M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.326M |
September 30, 2023 | 0.139M |
June 30, 2023 | 72.73M |
March 31, 2023 | 72.33M |
December 31, 2022 | 72.62M |
Date | Value |
---|---|
September 30, 2022 | 72.82M |
June 30, 2022 | 142.02M |
March 31, 2022 | 142.10M |
December 31, 2021 | 141.80M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.139M
Minimum
Sep 2023
142.10M
Maximum
Mar 2022
79.65M
Average
72.73M
Median
Jun 2023
Cash from Financing (TTM) Benchmarks
Aquestive Therapeutics Inc | 3.974M |
89bio Inc | 513.11M |
NovaBay Pharmaceuticals Inc | 4.971M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |